• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人烟雾病和综合征:现状和未来方向:美国心脏协会/美国中风协会的科学声明。

Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.

出版信息

Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.

DOI:10.1161/STR.0000000000000443
PMID:37609846
Abstract

Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. A writing group of experts was selected to conduct a literature search, summarize the current knowledge on the topic, and provide a road map for future investigation. The document presents an update in the definitions of moyamoya disease and syndrome, modern methods for diagnosis, and updated information on pathophysiology, epidemiology, and both medical and surgical treatment. Despite recent advancements, there are still many unresolved questions about moyamoya disease and syndrome, including lack of unified diagnostic criteria, reliable biomarkers, better understanding of the underlying pathophysiology, and stronger evidence for treatment guidelines. To advance progress in this area, it is crucial to acknowledge the limitations and weaknesses of current studies and explore new approaches, which are outlined in this scientific statement for future research strategies.

摘要

成人烟雾病和烟雾综合征是罕见疾病,具有较高的发病率和死亡率。我们选择了一组专家撰写小组进行文献检索,总结了该主题的现有知识,并为未来的研究提供了路线图。本文更新了烟雾病和烟雾综合征的定义、现代诊断方法,以及病理生理学、流行病学、内科和外科治疗的最新信息。尽管最近取得了一些进展,但烟雾病和烟雾综合征仍有许多悬而未决的问题,包括缺乏统一的诊断标准、可靠的生物标志物、对潜在病理生理学的更好理解,以及治疗指南的更强证据。为了推动该领域的进展,必须认识到当前研究的局限性和弱点,并探讨新的方法,本科学声明为未来的研究策略勾勒出了这些方法。

相似文献

1
Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.成人烟雾病和综合征:现状和未来方向:美国心脏协会/美国中风协会的科学声明。
Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.
2
Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association.新生儿和儿童脑卒中的管理:美国心脏协会/美国卒中协会的科学声明。
Stroke. 2019 Mar;50(3):e51-e96. doi: 10.1161/STR.0000000000000183.
3
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.将中风纳入心血管风险预测工具:美国心脏协会/美国中风协会向医疗保健专业人员发出的声明。
Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24.
4
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.静脉注射阿替普酶用于急性缺血性脑卒中的纳入和排除标准的科学依据:美国心脏协会/美国卒中协会医疗保健专业人员的声明。
Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22.
5
Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.中风后抑郁症:美国心脏协会/美国中风协会为医疗保健专业人员发布的科学声明。
Stroke. 2017 Feb;48(2):e30-e43. doi: 10.1161/STR.0000000000000113. Epub 2016 Dec 8.
6
Moyamoya Disease in Children: Results From the International Pediatric Stroke Study.儿童烟雾病:国际儿科卒中研究结果
J Child Neurol. 2017 Oct;32(11):924-929. doi: 10.1177/0883073817718730. Epub 2017 Jul 17.
7
Moyamoya disease: case report and literature review.烟雾病:病例报告及文献综述
J Am Osteopath Assoc. 2009 Oct;109(10):547-53.
8
Moyamoya disease: current concepts and future perspectives.烟雾病:当前概念与未来展望。
Lancet Neurol. 2008 Nov;7(11):1056-66. doi: 10.1016/S1474-4422(08)70240-0.
9
2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.《2021年烟雾病管理日本指南:烟雾病研究委员会和日本卒中协会指南》
Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):165-170. doi: 10.2176/jns-nmc.2021-0382. Epub 2022 Feb 22.
10
Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association.伴有肿胀的脑梗死和小脑梗死管理建议:美国心脏协会/美国中风协会给医疗专业人员的声明
Stroke. 2014 Apr;45(4):1222-38. doi: 10.1161/01.str.0000441965.15164.d6. Epub 2014 Jan 30.

引用本文的文献

1
The impact of anesthesia methods on early postoperative cognitive function in Moyamoya disease patients after vascular bypass surgery.麻醉方法对烟雾病患者血管搭桥术后早期认知功能的影响。
Medicine (Baltimore). 2025 Aug 29;104(35):e43317. doi: 10.1097/MD.0000000000043317.
2
Anesthetic Management in Combined Off-Pump CABG and EC-IC Bypass for CAD and Moyamoya Disease.非体外循环冠状动脉旁路移植术与颅外-颅内血管搭桥术联合治疗冠心病和烟雾病的麻醉管理
JACC Case Rep. 2025 Aug 20;30(24):104752. doi: 10.1016/j.jaccas.2025.104752.
3
Infections in Moyamoya Phenomenon: Current Evidence and Future Horizons-Narrative Review.
烟雾病现象中的感染:当前证据与未来展望——叙述性综述
Int J Gen Med. 2025 Jul 22;18:4027-4040. doi: 10.2147/IJGM.S532425. eCollection 2025.
4
Angiogenesis-related genes and immune microenvironment in moyamoya disease: a transcriptomic and functional analysis.烟雾病中血管生成相关基因与免疫微环境:转录组学与功能分析
Orphanet J Rare Dis. 2025 Jul 28;20(1):385. doi: 10.1186/s13023-025-03945-4.
5
Clinical and radiological course of asymptomatic and hemodynamically stable moyamoya disease: a systematic review and meta-analysis.无症状且血流动力学稳定的烟雾病的临床及影像学病程:一项系统评价与荟萃分析
Front Neurol. 2025 Jul 8;16:1626817. doi: 10.3389/fneur.2025.1626817. eCollection 2025.
6
Exploring the Real Mental Experience of Patients with Moyamoya Disease: A Qualitative Analysis.探索烟雾病患者的真实心理体验:一项定性分析。
Patient Prefer Adherence. 2025 Jul 7;19:1937-1950. doi: 10.2147/PPA.S527947. eCollection 2025.
7
Measurement accuracy and practicality of O-gas PET using a high-sensitivity whole-body PET/CT scanner.使用高灵敏度全身PET/CT扫描仪进行氧气气体PET的测量准确性和实用性。
Ann Nucl Med. 2025 Jun 25. doi: 10.1007/s12149-025-02073-0.
8
Long-Term Outcomes in Patients With Hemorrhagic Moyamoya Disease Combined With Hypertension After Encephaloduroarteriosynangiosis.脑-硬脑膜-动脉血管融通术后出血型烟雾病合并高血压患者的长期预后
J Am Heart Assoc. 2025 Jun 17;14(12):e039054. doi: 10.1161/JAHA.124.039054. Epub 2025 Jun 16.
9
DNA methylation profiles reveals STAB1-mediated endothelial cell and immune cell interactions in Moyamoya disease.DNA甲基化谱揭示了烟雾病中STAB1介导的内皮细胞与免疫细胞相互作用。
Clin Transl Med. 2025 Jun;15(6):e70367. doi: 10.1002/ctm2.70367.
10
Integrative molecular subtyping and diagnostic model construction for Moyamoya disease based on diverse programmed cell death gene patterns.基于多种程序性细胞死亡基因模式的烟雾病综合分子亚型分析及诊断模型构建
Orphanet J Rare Dis. 2025 Jun 3;20(1):268. doi: 10.1186/s13023-025-03816-y.